Combidex Broad Indication Appropriateness To Be Topic For Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA questions whether Combidex can be used to detect metastatic lymph nodes in a broad range of cancer types. The agency will also ask the committee to discuss the product’s risk of anaphylactic/anaphylactoid reactions and recommend strategies to mitigate the risk.